HB 3267 Oregon House · 2021 Regular Session

Relating to the price of prescription drugs.

Summary
Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or are expected to create affordability challenges for health systems and patients in Oregon or health inequities for communities of color. Requires board to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board. Establishes Prescription Drug Affordability Stakeholder Council to assist board in carrying out its duties.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2021
Committee Review
Floor Vote
Governor
Introduced Feb 23, 2021 Last action Jun 27, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
1
Committee
2
Jun 27, 2021
Lower · Passed
In committee upon adjournment.
lower
Feb 26, 2021
Committee
Referred to Health Care with subsequent referral to Ways and Means.
lower
Feb 23, 2021
Introduced
First reading. Referred to Speaker's desk.
lower
1 primary · 1 co-sponsor

Sponsors